8-KShareholder Matters

DEXCOM INC 8-K Report, Shareholder Vote Results (May 28, 2026)

Filed May 28, 2026For Securities:DXCM

Summary

DexCom, Inc. (DXCM) held its 2026 Annual Meeting of Stockholders on May 27, 2026, where key corporate governance and operational matters were presented to shareholders for a vote. The meeting saw strong participation, with a quorum established by the presence of 336,525,352 shares, representing over 87% of the outstanding common stock as of the April 1, 2026 record date. The primary outcomes of the meeting include the re-election of all twelve nominated directors to the board, each for a term extending to the 2027 annual meeting. Furthermore, stockholders overwhelmingly ratified the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The compensation of the company's named executive officers was also approved on an advisory, non-binding basis.

Key Highlights

  • 1All twelve director nominees were successfully elected to the DexCom Board of Directors, with substantial 'For' votes across all candidates.
  • 2The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026 was ratified with overwhelming support.
  • 3Stockholders approved, on an advisory basis, the compensation of DexCom's named executive officers.
  • 4A significant majority of outstanding shares (over 87%) were represented at the meeting, indicating strong shareholder engagement.
  • 5Director elections saw strong support, with most nominees receiving over 300 million 'For' votes, demonstrating confidence in the board's leadership.
  • 6Broker non-votes were noted in director elections, a common occurrence reflecting shares held in street name where instructions were not provided by the beneficial owner.

Frequently Asked Questions

The main outcomes were the election of twelve directors to the board, the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2026, and the advisory approval of named executive officer compensation. All proposals received significant shareholder support.

The ratification of Deloitte & Touche LLP signifies shareholder confidence in the company's auditor, which plays a critical role in ensuring the integrity and accuracy of DexCom's financial reporting.

This means shareholders voted on whether they approve of the compensation paid to the company's top executives. While the vote is non-binding, it provides valuable feedback to the board and compensation committee regarding shareholder sentiment on executive pay.

A total of 336,525,352 shares were present in person or by proxy, which constituted a quorum for the transaction of business. This represents a substantial majority of the outstanding shares.